1-8 of 8
Adriana Albini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cancer Prevention and Interception: A New Era for Chemopreventive Approaches

Adriana Albini, Andrea DeCensi, Franco Cavalli, Alberto Costa
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (17): 4322–4327.
https://doi.org/10.1158/1078-0432.CCR-16-0695
Published: 31 August 2016
View article titled, Cancer Prevention and Interception: A New Era for Chemopreventive Approaches
Open the PDF for Cancer Prevention and Interception: A New Era for Chemopreventive Approaches in another window
Journal Articles

Angiogenesis success and pitfalls in diagnosis, therapy and cancer prevention

Adriana Albini
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (19_Supplement): PL7-2.
https://doi.org/10.1158/DIAG-10-PL7-2
Published: 15 August 2014
View article titled, Angiogenesis success and pitfalls in diagnosis, therapy and cancer prevention
Journal Articles

Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells

Roberto Bianco, Roberta Rosa, Vincenzo Damiano, Gennaro Daniele, Teresa Gelardi, Sonia Garofalo, Valeria Tarallo, Sandro De Falco, Davide Melisi, Roberto Benelli, Adriana Albini, Anderson Ryan, Fortunato Ciardiello, Giampaolo Tortora
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (16): 5069–5080.
https://doi.org/10.1158/1078-0432.CCR-07-4905
Published: 12 August 2008
View article titled, Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells
Open the PDF for Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Prevention and Treatment of Experimental Estrogen Receptor–Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268

Karen Liby, Renee Risingsong, Darlene B. Royce, Charlotte R. Williams, Mark M. Yore, Tadashi Honda, Gordon W. Gribble, William W. Lamph, Nicola Vannini, Ilaria Sogno, Adriana Albini, Michael B. Sporn
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (14): 4556–4563.
https://doi.org/10.1158/1078-0432.CCR-08-0040
Published: 15 July 2008
View article titled, Prevention and Treatment of Experimental Estrogen Receptor–Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268
Open the PDF for Prevention and Treatment of Experimental Estrogen Receptor–Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268 in another window
Journal Articles

Molecular Pathways for Cancer Angioprevention

Adriana Albini, Douglas M. Noonan, Nicoletta Ferrari
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (15): 4320–4325.
https://doi.org/10.1158/1078-0432.CCR-07-0069
Published: 01 August 2007
View article titled, Molecular Pathways for Cancer Angioprevention
Open the PDF for Molecular Pathways for Cancer Angioprevention in another window
Journal Articles

The Transforming Growth Factor-β Family Members Bone Morphogenetic Protein-2 and Macrophage Inhibitory Cytokine-1 as Mediators of the Antiangiogenic Activity of N-(4-Hydroxyphenyl)Retinamide

Nicoletta Ferrari, Ulrich Pfeffer, Raffaella Dell'Eva, Claudia Ambrosini, Douglas M. Noonan, Adriana Albini
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (12): 4610–4619.
https://doi.org/10.1158/1078-0432.CCR-04-2210
Published: 15 June 2005
View article titled, The Transforming Growth Factor-β Family Members Bone Morphogenetic Protein-2 and Macrophage Inhibitory Cytokine-1 as Mediators of the Antiangiogenic Activity of <em>N</em>-(4-Hydroxyphenyl)Retinamide
Open the PDF for The Transforming Growth Factor-β Family Members Bone Morphogenetic Protein-2 and Macrophage Inhibitory Cytokine-1 as Mediators of the Antiangiogenic Activity of <em>N</em>-(4-Hydroxyphenyl)Retinamide in another window
Journal Articles

Mechanisms of Inhibition of Tumor Angiogenesis and Vascular Tumor Growth by Epigallocatechin-3-Gallate

Gianfranco Fassina, Roberta Venè, Monica Morini, Simona Minghelli, Roberto Benelli, Douglas M. Noonan, Adriana Albini
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (14): 4865–4873.
https://doi.org/10.1158/1078-0432.CCR-03-0672
Published: 21 July 2004
View article titled, Mechanisms of Inhibition of Tumor Angiogenesis and Vascular Tumor Growth by Epigallocatechin-3-Gallate
Open the PDF for Mechanisms of Inhibition of Tumor Angiogenesis and Vascular Tumor Growth by Epigallocatechin-3-Gallate in another window
Journal Articles

Inhibition of Kaposi’s Sarcoma in Vivo by Fenretinide

Nicoletta Ferrari, Monica Morini, Ulrich Pfeffer, Simona Minghelli, Douglas M. Noonan, Adriana Albini
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 6020–6029.
Published: 15 December 2003
View article titled, Inhibition of Kaposi’s Sarcoma <em>in Vivo</em> by Fenretinide
Open the PDF for Inhibition of Kaposi’s Sarcoma <em>in Vivo</em> by Fenretinide in another window